🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
NCT06183736Advanced Solid Tumors
Convalife (Shanghai) Co., Ltd.
Phase 2
98
Beijing
2023-12-20
Recruiting
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
NCT05916248Advanced Solid Tumor
Ruijin Hospital
Phase EARLY_PHASE1
34
Shanghai
2023-12-20
Recruiting
Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma
NCT06082102Relapsed/Refractory Marginal Zone Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 3
324
Bengbu, Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanchang, Dalian
2023-12-19
Active, closed
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
NCT06118411Vitiligo
AbbVie
Phase 3
614
Beijing, Guangzhou, Wuhan, Xi'an, Jinan, Shanghai, Chengdu, Tianjin
2023-12-19
Recruiting
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
NCT06190665Hepatocellular Carcinoma
Zhongda Hospital
Not applicable
188
Beijing, Nanjing
2023-12-19
Recruiting
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147Pancreatic Cancer
Fudan University
Observational
276
Shanghai
2023-12-18
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,314
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Changsha, Nanjing
2023-12-18
Recruiting
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
NCT06171061Chronic Coronary Syndrome
Shandong First Medical University
Phase 4
1,200
Chongqing, Zhengzhou, Binzhou, Dezhou, Feicheng, Jinan, Liaocheng, Linqing
2023-12-18
Recruiting
VR Interventions to Reduce the Prevalence of Delirium in ICU Patients
NCT05525702Delirium
Peking Union Medical College Hospital
Not applicable
102
Beijing
2023-12-18
Recruiting
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
NCT06007729Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company
Phase 2
170
Hefei, Beijing, Fuzhou, Guangzhou, Zhuhai, Nanning, Harbin, Zhengzhou
2023-12-18
Recruiting
Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
NCT06249308Ovarian Cancer
Fudan University
Observational
168
Guangzhou, Shenyang, Shanghai
2023-12-18
Recruiting
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
NCT06014190Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Endometrial Cancer
Hansoh BioMedical R&D Company
Phase 2
460
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Haikou, Shijiazhuang
2023-12-18
Active, closed
Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
NCT06187506Non-muscle Invasive Bladder Cancer, HER-2 Protein Overexpression
Fudan University
Phase 2
20
Shanghai
2023-12-18
Recruiting
Washed Microbiota Transplantation for Malnutrition
NCT06447220Malnutrition
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2023-12-17
Recruiting
Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study
NCT06216782Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Observational
2,000
Shanghai
2023-12-16
Recruiting
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
NCT06359795Thyroid Eye Disease
Peking University Third Hospital
Not applicable
50
Beijing
2023-12-15
Recruiting
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
NCT06355258COVID 19 Associated Coagulopathy
Westlake University
Phase 1
80
Shaoxing
2023-12-15
Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
NCT06170788Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC
Phase 3
614
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Zhanjiang, Shijiazhuang, Harbin
2023-12-15
Not yet open
A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
NCT06152978Esophageal Squamous Cell Carcinoma
Fudan University
Phase 2
182
Shanghai
2023-12-15
Recruiting
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
NCT06255223Renal Cell Carcinoma, Radiotherapy, Immune Checkpoint Inhibitor
Jinling Hospital, China
Phase 2
35
Nanjing
2023-12-15
Recruiting
Atrophic Gastritis Predicts the Risk of Gastric Cancer
NCT06203327Atrophic Gastritis
Shanghai Jiao Tong University School of Medicine
Observational
2,042
Shanghai
2023-12-15
Recruiting
A Study of YL202 in Selected Patients With Advanced Solid Tumors
NCT06107686NSCLC, Breast Cancer, HNSCC, Locally Advanced or Metastatic Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 2
200
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Meizhou, Shantou, Guilin
2023-12-15
Not yet open
Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity
NCT06137352HPV Infection, HPV Vaccine, Cervical Cancer Prevention
Fujian Maternity and Child Health Hospital
Observational
3,000
Fuzhou
2023-12-15
Recruiting
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
NCT06750172Primary Aldosteronism
Peking Union Medical College Hospital
Observational
33
Beijing
2023-12-15
Recruiting
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222Carcinoma, Non-small Cell Lung Cancer
Shanghai Chest Hospital
Observational
200
Shanghai
2023-12-15
Recruiting
ALI/ARDS Clinical Sub-phenotyping Study
NCT06123962Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
China-Japan Friendship Hospital
Observational
1,500
Beijing
2023-12-14
Recruiting
The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites
NCT06433869Malignant Ascites
Sun Yat-sen University
Phase 2
60
Guangzhou
2023-12-14
Active, closed
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06082635Non Small Cell Lung Cancer
Shenzhen TargetRx Co., Ltd.
Phase 3
321
Guangzhou
2023-12-14
Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
NCT06129864Locally Advanced Head and Neck Squamous Cell Carcinoma
AstraZeneca
Phase 3
1,145
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongwan, Fuzhou
2023-12-14
Recruiting
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
NCT06123884Cervical Cancer
Bio-Thera Solutions
Phase 2/3
526
Wuhan
2023-12-13
Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT06219941Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
AstraZeneca
Phase 2
226
Changsha, Chengdu
2023-12-13
Recruiting
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
NCT06127446Ovarian Cancer
National Health Research Institutes, Taiwan
Observational
300
2023-12-13
Active, closed
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
NCT05734105GIST
Deciphera Pharmaceuticals, LLC
Phase 3
54
2023-12-13
Active, closed
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473Multiple Sclerosis
Sanofi
Phase 3
1,655
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou
2023-12-13
Recruiting
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
NCT06088030Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations
Yang Li
Phase 2
50
Guangzhou
2023-12-13
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
NCT06136559Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Merck Sharp & Dohme LLC
Phase 3
1,200
Hefei, Beijing, Chongqing, Guangzhou, Liuzhou, Nanning, Guiyang, Haikou
2023-12-13
Active, closed
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
NCT05991323Prurigo Nodularis
Sanofi
Observational
100
Guangzhou, Xi'an, Jinan, Hangzhou, Wenzhou, Beijing, Shanghai, Shenzhen
2023-12-12
Recruiting
Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye
NCT07634913Artifical Intelligence, Cataract, Pterygium, Keratopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
3,000
Guangzhou
2023-12-12
Recruiting
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
NCT05861895Solid Tumors, Adult
HighField Biopharmaceuticals Corporation
Phase 1
84
Guangzhou
2023-12-12
Active, closed
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)
NCT06160908Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
38
Beijing
2023-12-12
Recruiting
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
NCT06122831Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
92
Guangzhou, Nanning, Cangzhou, Chengde, Tangshan, Xingtai, Harbin, Zhengzhou
2023-12-12
Recruiting
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
NCT06141460Neovascular Age-related Macular Degeneration
Shanghai Refreshgene Technology Co., Ltd.
Phase 1/2
48
Tianjin
2023-12-12
Recruiting
A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer
NCT06042894Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
58
Shanghai
2023-12-12
Recruiting
A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs
NCT07057622NETS Ga68 Lu177
HTA Co., Ltd.
Phase 3
184
Beijing
2023-12-12
Active, closed
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
NCT06276998Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd
Phase 3
430
Beijing
2023-12-12
Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
NCT06253130Advanced Solid Tumor
Eikon Therapeutics
Phase 1/2
156
Guangzhou, Shijiazhuang, Jinan, Hangzhou, Chongqing, Fuzhou, Shanghai
2023-12-11
Recruiting
Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
NCT06375161B Cell Malignancies
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2023-12-11
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05995353Crohn's Disease
AbbVie
Phase 3
110
Beijing, Guangzhou, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2023-12-11
Active, closed
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
NCT06132256Idiopathic Pulmonary Fibrosis
Syndax Pharmaceuticals
Phase 2
145
2023-12-11
Recruiting
PostoperAtive Neurocognitive Dysfunction After Major AbdomiNal Surgery (PANDAMAN)
NCT06182215Elective Major Abdominal Surgery
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
500
Guangzhou
2023-12-11
Recruiting
Optimal Evaluation to Reduce Cardiovascular Imaging Testing
NCT05640752Chronic Coronary Syndrome
Tianjin Chest Hospital
Not applicable
800
Beijing, Lanfang, Tianjin
2023-12-11
Active, closed
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
NCT06065748Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche
Phase 3
1,050
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2023-12-11
Recruiting
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
NCT06177015Metastatic Prostate Cancer, Intermitent Anti-androgen Therapy
The First Affiliated Hospital with Nanjing Medical University
Phase 3
200
Nanjing
2023-12-11
Recruiting
Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina)
NCT06275009Lifestyle, Physical Fitness, Cardiovascular Diseases
China National Center for Cardiovascular Diseases
Observational
18,512
Beijing
2023-12-11
Recruiting
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
NCT05965856Urothelial Carcinoma, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
52
Shanghai
2023-12-11
Recruiting
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
NCT06219096Malignant Tumor of Liver, Randomized Controlled Trial
West China Hospital
Not applicable
100
Chengdu
2023-12-10
By invitation
Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
NCT06776835Stomach Neoplasms
Affiliated Hospital of Nantong University
Observational
300
Nantong
2023-12-10
Recruiting
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
NCT06177925Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms
Nanfang Hospital, Southern Medical University
Phase 2
62
Guangzhou
2023-12-10
Recruiting
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
NCT05939167AIDS
Cell Energy Life Sciences Group Co. LTD
Phase 1/2
150
Beijing, Shenzhen, Shijiazhuang
2023-12-10
Recruiting
The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study
NCT06188650Non-Small Cell Lung Cancer
Ningbo Medical Center Lihuili Hospital
Not applicable
30
Ningbo
2023-12-09
Recruiting
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
NCT06157827Advanced Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2
178
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Luoyang
2023-12-08
Recruiting
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
NCT05947344AML, Adult
Zhejiang ACEA Pharmaceutical Co. Ltd.
Phase 1
84
Hangzhou
2023-12-08
Recruiting
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NCT06168032COVID-19 Recurrent, Lung Cancer, Vaccination, Antibody
Peking Union Medical College Hospital
Not applicable
1,224
Beijing
2023-12-08
Recruiting
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer
NCT06205927Non-small Cell Lung Cancer
Jian Chen
Phase 2
77
Shanghai
2023-12-07
Active, closed
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
NCT06150014Chronic Hepatitis b
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
88
Chongqing, Xi'an
2023-12-07
Recruiting
SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
NCT06219980SBRT
Sun Yat-sen University
Phase 2
25
Guangzhou
2023-12-07
Active, closed
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
NCT05976243Chronic Inducible Urticaria
Novartis Pharmaceuticals
Phase 3
362
Fuzhou, Guangzhou, Changsha, Wuxi, Changchun, Jinan, Chengdu, Ürümqi
2023-12-07
Recruiting
Social Feedback and Dysfunctional Risk Taking in NSSI Adolescents
NCT05981677Nonsuicidal Self Injury, Risk-Taking
University of Electronic Science and Technology of China
Observational
80
Chengdu
2023-12-06
Recruiting
Altered Neural Pain Empathic Reactivity in NSSI Adolescents
NCT05968313Nonsuicidal Self Injury, Pain Empathy
University of Electronic Science and Technology of China
Observational
80
Chengdu
2023-12-06
Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
NCT06216041Nonalcoholic Steatohepatitis (NASH)
Changchun Intellicrown Pharmaceutical Co. LTD
Phase 1
138
Changchun
2023-12-06
Recruiting
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer
NCT06155305Organoids, Breast Cancer, Neoadjuvant Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
58
Hangzhou
2023-12-06
Active, closed
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
NCT06132958Endometrial Cancer
Merck Sharp & Dohme LLC
Phase 3
710
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Shantou, Zhanjiang, Nanning
2023-12-06
Recruiting
Emotion Regulation Dysfunctions in NSSI Adolescents in Naturalistic Contexts
NCT05907421Nonsuicidal Self Injury, Emotion Regulation
University of Electronic Science and Technology of China
Observational
80
Chengdu
2023-12-06
Recruiting
Impact of Emotional Reactivity on Dysfunctional Decision-Making in NSSI Adolescents
NCT05981612Nonsuicidal Self Injury, Prediction Errors
University of Electronic Science and Technology of China
Observational
80
Chengdu
2023-12-06
Recruiting
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
NCT06069830NK-T-Cell Lymphoma, Extranodal
Ruijin Hospital
Not applicable
89
Shanghai
2023-12-06
Recruiting
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
NCT06106945Multiple Myeloma
AstraZeneca
Phase 1/2
226
Beijing, Changsha, Guangzhou, Shenyang
2023-12-05
Recruiting
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174Lupus Nephritis
Chinese SLE Treatment And Research Group
Observational
100
Beijing
2023-12-05
Not yet open
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
NCT06173726Locally Advanced/Metastatic Liver Cancer
BioSyngen Pte Ltd
Phase EARLY_PHASE1
6
Shenzhen
2023-12-05
Recruiting
Evaluation of Membrane Lung Function in High-altitude Regions
NCT06152744Extracorporeal Membrane Oxygenation, Membrane Lung Function, High Altitude
Beijing Chao Yang Hospital
Observational
40
Beijing
2023-12-05
Recruiting
A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
NCT05969171Pancreatic Cancer Metastatic
Fudan University
Phase 2
65
Shanghai
2023-12-05
By invitation
The Differences in the Psychological States of Patients with Different Chronic Hip Pain
NCT06611722Psychological Disorders, Hip Pain Chronic
ChunBao Li
Observational
70
Beijing
2023-12-05
Recruiting
Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
NCT06109337ADHD, Immune System, Clinical Syndrome
First Affiliated Hospital of Zhejiang University
Observational
100
Hangzhou
2023-12-04
Active, closed
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
NCT06109779Biliary Tract Cancer
AstraZeneca
Phase 3
760
Beijing, Changchun, Changsha, Chengdu, Deyang, Fuzhou, Guangzhou, Guiyang
2023-12-04
Active, closed
A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)
NCT06118333Nasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
386
Guangzhou
2023-12-04
Recruiting
Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
NCT06224257Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
41
Hefei, Zhoukou, Tianjin
2023-12-03
Recruiting
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
NCT06512207NSCLC, Stage III, NSCLC, Stage IV
Jinzhou Medical University
Not applicable
80
Zhengzhou
2023-12-03
Active, closed
Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients
NCT07140406Cerebral Infarction
Qilu Hospital of Shandong University
Not applicable
105
Jinan
2023-12-02
Recruiting
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
NCT05998759Connective Tissue Diseases, Thrombocytopenia
Beijing Hospital
Phase 2
296
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Hohhot, Shenyang
2023-12-02
Recruiting
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
NCT06079983Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 3
400
Guangzhou, Shanghai, Anyang, Baoding, Beijing, Changchun, Changde, Changsha
2023-12-01
Not yet open
Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC
NCT06127329Carcinoma, Non-Small Cell Lung
Gang Wu
Not applicable
70
Zhengzhou
2023-12-01
Active, closed
Can a Smartphone Listen to Your Heart? A Performance Study on Detecting Abnormalities in Your Heart Sounds
NCT06070298Valvular Heart Disease, Heart Murmurs, Cardiovascular Abnormalities
Wong Chun Ka
Observational
577
Hong Kong
2023-12-01
By invitation
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
NCT06777173Chronic Hepatitis b, Immunotherapy
Beijing Ditan Hospital
Not applicable
180
Beijing
2023-12-01
Recruiting
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
NCT06463717Multiple Myeloma, Minimal Residual Disease
First Affiliated Hospital of Zhejiang University
Observational
210
Hangzhou
2023-12-01
Not yet open
Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement
NCT06131489Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus, Bowel Resection
Beijing Friendship Hospital
Observational
20
Beijing
2023-12-01
Recruiting
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
NCT06417736Endometrial Cancer Stage I, Endometrial Hyperplasia
Women's Hospital School Of Medicine Zhejiang University
Not applicable
75
Hangzhou
2023-12-01
By invitation
Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
NCT06643858Healthy, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, Neurodegenerative Diseases
Beijing Tiantan Hospital
Observational
10,000
Beijing
2023-12-01
Recruiting
Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients
NCT06023212Metastasis Spinal Tumor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
150
Hangzhou
2023-12-01
Recruiting
Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
NCT06354218Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2023-12-01
Active, closed
Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.
NCT06232486Postherpetic Neuralgia
Feng Gao
Observational
144
Wuhan
2023-12-01
Recruiting
Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients
NCT06108830Sleep Disturbance
Tianjin Medical University General Hospital
Not applicable
400
Tianjin
2023-12-01
Rows per page Showing 14101–14200 of 19052
Previous 140 141 142 143 144 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=142

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.